Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > UCSB Chosen for Two NIH Nanotechnology Grants

Abstract:
UCSB is Only University to Participate in Two PEN Nanotech Grants

Developing Novel Technologies to Diagnose and Treat Diseases of the Heart and Lungs

UCSB Chosen for Two NIH Program of Excellence (PEN) in Nanotechnology Grants

Santa Barbara, CA | July 14, 2005

The University of California, Santa Barbara, has been chosen to participate in two interdisciplinary, multi-university research efforts as a Program of Excellence in Nanotechnology (PEN). The awards by the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) are part of NIH's strategy to accelerate progress in medical research through innovative technology and interdisciplinary research. Both research efforts bring together bioengineers, materials scientists, biologists and physicians working in interdisciplinary teams.

  1. UCSB will be working with Washington University in St. Louis and UC Berkeley, under a $12.5 million grant, to develop nanoscale agents to provide early diagnosis and treatment of pulmonary artery disease. At UCSB, the project is being led by Professor Craig Hawker, Director of the Materials Research Lab.
  2. UCSB will be teaming with The Burnham Institute and Scripps Research Institute, both of La Jolla, Calif., to apply a $13 million grant to develop ways to use nanotechnologies in the design of new ways to detect, monitor, treat and eliminate vulnerable plaque, the probable cause of death from sudden cardiac arrest. UCSB professors participating in the project include Matthew V. Tirrell, PhD, Dean of the college of Engineering and professor of chemical engineering; Andrew N. Cleland, PhD, associate professor pf physics; Patrick Daughterty, PhD, associate professor of chemical engineering; Samir Mitragotri, PhD, assistant professor of chemical engineering; and Joseph Zasadzinski, PhD, professor of chemical engineering.

The team coordinated by Profess Karen L. Wooley at Washington University in St. Louis and led at UCSB by Professor Craig Hawker will use nanoscale materials as carriers for diagnostic systems and to deliver therapeutic agents. A major goal will be to develop ways to trigger a breakdown of the nanoparticles after a payload, such as a drug or antiviral agent, is delivered to a diseased zone. Targeted nanoparticles will search out arteries that are under stress or are diseased.

The group coordinated by The Burnham Institute will build "delivery vehicles" than can be used to transport drugs, imaging agents and nano-devices directly to locations where there is vulnerable plaque; design molecular nano-stents to physically stabilize vulnerable plaque and replace its fibrous cap with an anti-adhesive, anti-inflammatory surface; devise molecular switches that can sense and respond to the pathophysiology of atheroma (fatty deposits on arterial walls); and develop bi-nanoelectromechanical systems (called BioNEMS) that can sense and respond to vulnerable plaque, ultimately providing diagnostic and therapeutic capability.

####

Contact:
Barbara Bronson Gray
818.889.5415
bbgray@sbcglobal.net

Copyright © UCSB

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017

Nanomedicine

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Sensors detect disease markers in breath May 19th, 2017

Oddball enzyme provides easy path to synthetic biomaterials May 17th, 2017

The brighter side of twisted polymers: Conjugated polymers designed with a twist produce tiny, brightly fluorescent particles with broad applications May 16th, 2017

Announcements

Three-dimensional graphene: Experiment at BESSY II shows that optical properties are tuneable May 24th, 2017

Leti to Demo 1st Wireless UNB Transceiver for ‘Massive Internet of Things’ at RFIC 2017 and IMS 2017: Leti Will also Present Three Papers & Two Workshops on 5G Communications IC Design, from RF to mm-Wave, During IMS 2017 and RFIC 2017 in Hawaii May 24th, 2017

GLOBALFOUNDRIES and Chengdu Partner to Expand FD-SOI Ecosystem in China: More than $100M investment to establish a center of excellence for FDXTM FD-SOI design May 23rd, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project